Community Contributor
Member since 2025
Views7.5kTotal number of views
Followers129Total number of followers
Comments0Total number of comments

Stock Research Today, provides investors with real-time market analysis, expert research, and curated financial content to support smarter, data-driven investment decisions.

No link added
NarrativesWatchlists
RNXT logo
RenovoRx

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.Read more

View narrative
7.5k
users have viewed this narrative
17users have liked this narrative
3users have commented on this narrative
130users have followed this narrative
US$4.2
76.2% undervalued intrinsic discount
Fair Value
Profit Margin
36%
Future PE
15x
Price in 2029
US$10.53